Chronic plaque psoriasis, also known as psoriasis vulgaris (chronic stationary type). Plaque psoriasis is a common, chronic and inflammatory skin disorder.
Starting this month, Sotyktu (deucravacitinib), an oral treatment for moderate-to-severe plaque psoriasis in adults, receives health insurance benefits in Korea for treating adult patients with chr...
Chronic plaque psoriasis. Authoritative facts from DermNet New Zealand.
Efficacy of psoralen plus ultraviolet A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registry. by M Inzinger, B Heschl, W Weger, A...
주제어 *PSORIASIS *QUALITY of life *PATIENT compliance *PSORIATIC... of psoriasis has not been widely assessed in Polish population so far. This study aimed to investigate psoriasis...
Psoriasis is a chronic autoimmune skin disease. Learn the types, causes, risk factors, symptoms, diagnosis, treatment, medication, and prevention of psoriasis.
HUMIRA® (adalimumab) is a biologic for adults with moderate to severe chronic plaque psoriasis (PS). See Important Safety Info, including the BOXED WARNING.
As far as the field of dermatology is concerned, chronic plaque psoriasis is currently one of the most studied indications regarding the potential use of JAK inhibitors. The purpose of this...
Signs and symptoms Plaque psoriasis Psoriasis vulgaris (also known as chronic stationary psoriasis or plaque-like psoriasis) is the most common form and affects 85–90% of people with...
Abstract ; Background : Type 17 helper T cells have been suggested to play a pathological role in psoriasis. They secrete several proinflammatory cytokines, including interleukin-17A (also known as interleukin-17). We evaluated the safety and efficacy of ixekizumab (LY2439821), a humanized anti–interleukin-17 monoclonal antibody, for psoriasis treatment. Methods : In our phase 2, double-blind, placebo-controlled trial, we randomly assigned 142 patients with chronic moderate-to-severe plaque ps...